MADRIGAL PHARMACEUTICALS, INC. (MDGL) › Total AssetsMADRIGAL PHARMACEUTICALS, INC. (MDGL) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $54.07M2011: $42.32M2012: $103.02M2013: $95.20M2014: $100.67M2015: $363.6K2016: $41.21M2017: $192.31M2018: $485.43M2019: $442.06M2020: $287.00M2021: $273.33M2022: $362.57M2023: $640.55M2024: $1.04B2025: $1.26B$1.26B2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$1.26B+20.9%2024$1.04B+62.7%2023$640.55M+76.7%2022$362.57M+32.6%2021$273.33M-4.8%2020$287.00M-35.1%2019$442.06M-8.9%2018$485.43M+152.4%2017$192.31M+366.7%2016$41.21M+11234.5%2015$363.6K-99.6%2014$100.67M+5.7%2013$95.20M-7.6%2012$103.02M+143.4%2011$42.32M-21.7%2010$54.07M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share